Industri

Gland Pharma, Neuland Laboratories enter long-term CDMO...

The collaboration brings together Neuland’s API development capabilities and Gl...

IPC recognised as WHO-SEARN Regional Centre of Excellen...

Recognition comes during IPC's participation in the 10th Anniversary Meeting o...

Phylo and Chugai collaborate to deploy AI platform in d...

The move aims to address challenges in the sector where analytical work behind r...

AsymBio to secure $184m to support growth in biologics ...

The funds will be used for AsymBio’s principal business operations and drive fur...

Rx-to-OTC Is only the beginning: Why some brands grow a...

Vilas Hegade explains why commercial execution determines the success of Rx-to-...

Diversifying beyond the US market

India's next export wave will not be won on tariff advantage alone; mutual reco...

Ecobliss India CMD Chakravarthi AVPS receives Asia Busi...

Recognition acknowledges his contribution to advancing Indian pharmaceutical ca...

SCHOTT charts long-term roadmap for Type I pharmaceutic...

In an exclusive conversation with Sundeep Prabhu, Senior Vice President, Sales ...

Zydus receives USFDA approval for generic Indocyanine G...

Dr Sharvil Patel says the approval expands Zydus’ portfolio of injectable and i...

Howden India develops Cancer Care Group Policy; AstraZe...

Amit Agarwal explains how Howden India developed a cancer care policy for emplo...

Fermenta Biotech lists equity shares on NSE

Prashant Nagre says the NSE listing strengthens Fermenta’s capital market prese...

Curium to acquire Lantheus in all-cash deal worth up to...

The deal will take the Nasdaq-listed Lantheus private. Under the agreement, Curi...

FDA grants breakthrough therapy designation to Lilly’s ...

The designation is specifically for patients whose tumours demonstrate a KRAS G1...

Dr Reddy’s registers PD-1 inhibitor for recurrent or me...

Dr Rashem Mothilal explains how the registration aims to expand access to immun...

Ratio Therapeutics secures $70m Series C funding for ca...

The company said existing investors Duquesne Family Office and Bristol Myers Squ...

IMPACT Therapeutics grants Pharmanovia exclusive $488m ...

The agreement covers the use of senaparib as a maintenance monotherapy for adult...